Health Condition 1: C15-C26- Malignant neoplasms of digestive organs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)ASA I-III undergoing GastroIntestinal Cancer Surgeries 2) scheduled for elective open GI oncosurgeries
Exclusion criteria
Exclusion criteria: 1.Known allergy to Local Anaesthetic Agents and opioids 2.Patients on chronic opioid therapy 3.Patients with spine deformities, post spinal surgeries 4.Patients undergoing thoracic surgeries or VATS 5.Coagulopathy 6. Infection at the injection site 7. Pregnancy 8. Patient refusal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of pain relief between epidural bolus and continuous infusion of epidural morphine-ropivacaine combination using the Numeric Rating Scale (NRS) for pain and to correlate pain scores with serum interleukin levels (IL-6 and IL-10) in patients undergoing major gastrointestinal oncosurgeriesTimepoint: To compare the efficacy of pain relief between epidural bolus and continuous infusion of epidural morphine-ropivacaine combination using the Numeric Rating Scale (NRS) for pain and to correlate pain scores with serum interleukin levels (IL-6 and IL-10) in patients undergoing major gastrointestinal oncosurgeries for 48 hrs post op | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of postoperative rescue analgesia consumption Timepoint: Comparison of postoperative rescue analgesia consumption till 48hrs in postop period;Comparison of Intraoperative hemodynamics in these 2 groupsTimepoint: Till the end of surgery bt12-24 hrs duration;Comparison of Time to early mobilisation from bedTimepoint: within 1-2 week duration postop;Comparison of Length of Hospital stayTimepoint: 1 week -3 week;Comparison of quality of life at 3 monthsTimepoint: 3 months | — |
Countries
India
Contacts
AIIMS Rishikesh